Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Humoral correlates of protection against <i>Mycobacterium tuberculosis</i> following intravenous BCG vaccination in rhesus macaques.

iScience·2024
Same author

Markov Field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques.

bioRxiv : the preprint server for biology·2024
Same author

Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques.

Cell systems·2024
Same author

Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platform.

medRxiv : the preprint server for health sciences·2024
Same author

Antibody-Fab and -Fc features promote <i>Mycobacterium tuberculosis</i> restriction.

bioRxiv : the preprint server for biology·2024
Same author

Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2024

Related Experiment Video

Updated: May 6, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

13.8K

Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Margaret E Ackerman1, Galit Alter

  • 1Ragon Institute of MGH, MIT, and Harvard University, Cambridge, MA 02139, USA. galter@partners.org.

Current HIV Research
|November 7, 2013
PubMed
Summary

Antibodies bridge innate and adaptive immunity by engaging immune cells to clear infections. Optimizing antibody effector functions is key for vaccine-mediated protection, especially against HIV.

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.2K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.5K

Related Experiment Videos

Last Updated: May 6, 2026

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

13.8K
A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.2K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.5K

Area of Science:

  • Immunology
  • Infectious Disease Research
  • Vaccinology

Background:

  • Antibodies are crucial for immunity, linking innate and adaptive immune responses.
  • Antibody functions are complex, influenced by isotype, glycosylation, Fc receptors, and innate immune cells.
  • Innate immune cell recruitment by antibodies is vital for protection, as seen in human and macaque studies.

Purpose of the Study:

  • To explore the role of antibody effector functions in immunity.
  • To understand how antibodies engage innate immune cells for pathogen clearance.
  • To identify strategies for enhancing antibody-mediated protection against infections like HIV.

Main Methods:

  • Analysis of antibody isotype, subclass, and glycosylation impacts on effector functions.
  • Investigation of Fc receptor expression and activity.
  • Assessment of innate immune cell responses to opsonized particles.

Main Results:

  • Antibodies recruit innate immune cells to clear viral particles and infected cells.
  • Effector functions are critical for vaccine-mediated protection, including in HIV vaccine development.
  • Understanding antibody-Fc receptor interactions is essential for effective immune responses.

Conclusions:

  • Enhancing antibody effector functions is a promising strategy for improving protection against infections, including HIV.
  • Successful antibody-based interventions require precise control over antibody functional profiles and innate immune cell recruitment.
  • Further research is needed to optimize the elicitation of protective antibody subclasses and recruit relevant innate effector cells at infection sites.